28810 Federal Register / Vol. 75, No. 99 / Monday, May 24, 2010 / Notices 

ADSSP state grantees, as well as basic 

demographic information about service 

recipients. This revised version includes 

some revisions to the approved 2007 

version. The revised version would be 

in effect for the FY2011 reporting year 

and thereafter, while the current 

reporting tool, OMB Approval Number 

0985–0022, would be extended to the 

end of the FY2010 reporting cycle. 

The proposed FY2011 ADSSP–DCRT 

can be found on AoA’s Web site at: 

http://www.aoa.gov/AoARoot/ 

AoA_Programs/HCLTC/Alz_Grants/ 

docs/ADSSP.pdf. 

AoA estimates the burden of this 

collection of information as follows: 

1410 hours. 

Dated: May 18, 2010. 

Kathy Greenlee, 

Assistant Secretary for Aging. 

[FR Doc. 2010–12357 Filed 5–21–10; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable materials, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

General Medical Sciences Special Emphasis 

Panel; LPR. 

Date: May 28, 2010. 

Time: 9 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Room 

3AN12B, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Helen R. Sunshine, PhD, 

Chief, Office of Scientific Review, National 

Institute of General Medical Sciences, 

National Institutes of Health, Natcher 

Building, Room 3AN–12F, Bethesda, MD 

20892, (301) 594–2881, 

sunshinh@nigms.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.375, Minority Biomedical 

Research Support; 93.821, Cell Biology and 

Biophysics Research; 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.862, Genetics and 

Developmental Biology Research; 93.88, 

Minority Access to Research Careers; 93.96, 

Special Minority Initiatives, National 

Institutes of Health, HHS) 

Dated: May 18, 2010. 

Ann Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12446 Filed 5–21–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Conducting 

Public Health Research in Kenya 

(Panel C), Funding Opportunity 

Announcement (FOA) GH10–003, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 12 p.m.–3 p.m., June 24, 

2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Conducting Public Health 

Research in Kenya (Panel C),’’ FOA GH10– 

003. 

Contact Person for More Information: 

Christine Morrison, PhD, Scientific Review 

Administrator, CDC, 1600 Clifton Road, NE., 

Mailstop D72, Atlanta, GA 30333, Telephone: 

(404) 639–3098. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 14, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12355 Filed 5–21–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Addressing 

Emerging Infectious Diseases and 

Related Public Health Concerns in 

India, Funding Opportunity 

Announcement (FOA) GH10–002, Initial 

Review 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 11 a.m.–2 p.m., July 1, 

2010 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Addressing Emerging Infectious 

Diseases and Related Public Health Concerns 

in India,’’ FOA GH10–002. 

Contact Person for More Information: 

Hylan D. Shoob, PhD, M.S.P.H., Scientific 

Review Officer, CDC, 1600 Clifton Road, NE., 

Mailstop D72, Atlanta, GA 30333, Telephone: 

(404) 639–4796. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 14, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12356 Filed 5–21–10; 8:45 am] 

BILLING CODE 4163–18–P 

WReier-Aviles on DSKGBLS3C1PROD with NOTICES